Cardiff Oncology, Inc (CRDF) insider trading

Every open-market stock purchase and sale by Cardiff Oncology, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Gary W Pace (Insider), $36.6K, 3 months ago.

Last 12 months: insiders bought $66.5K (2 buys) and sold $0 (0 sales). Last close $1.50 on Jun 4, 2026.

Recent CRDF insider trades

DateInsiderTradeValue
Jun 18, 2026Gary W Pace (Insider)Bought$36.6K
Jun 18, 2026Mani Mohindru (CEO)Bought$29.9K
Jun 11, 2026Renee P Tannenbaum (Insider)Bought (not open market)—
Jun 11, 2026Gary W Pace (Insider)Bought (not open market)—
Jun 11, 2026Rodney S Markin (Insider)Bought (not open market)—
Jun 11, 2026James O Armitage (Insider)Bought (not open market)—
Jun 11, 2026Lale White (Insider)Bought (not open market)—
Apr 27, 2026Ajay Aggarwal (COO)Bought (not open market)—
Apr 14, 2026Tod Smeal (C-suite exec)Bought (not open market)—
Apr 6, 2026Joshua B Muntner (CFO)Bought (not open market)—
Apr 6, 2026Joshua B Muntner (CFO)Bought (not open market)—
Mar 31, 2026Mani Mohindru (CEO)Bought (not open market)—
Feb 17, 2026Mani Mohindru (CEO)Bought (not open market)—
Feb 13, 2026Brigitte Ute Lindsay (C-suite exec)Bought (not open market)—

Who's trading CRDF

Get free alerts when an insider at Cardiff Oncology, Inc files a new trade →